In a mouse model and samples from patients with non-small cell lung cancer (NSCLC), NIR178 showed an ability to reduce lung metastasis and prevent the immune-evasive mechanisms mediated by A2AR [72]. Here, ADORA2A is linked to non-small cell lung carcinoma.